
欧洲内皮功能障碍市场预测至 2028 年 - 区域分析 - 按原因(高血压、糖尿病、高胆固醇血症、白塞氏病、肥胖等)、测试类型 [侵入性测试和非侵入性测试(血流介导的扩张、外周动脉检查)眼压测量 (PAT)、静脉闭塞体积描记术、循环标记等)] 和最终用户(医院、门诊手术中心、专科诊所等)
No. of Pages: 122 | Report Code: BMIRE00029139 | Category: Life Sciences
No. of Pages: 122 | Report Code: BMIRE00029139 | Category: Life Sciences
生活方式的改变导致糖尿病、高血压、血脂异常和肥胖会增加内皮功能障碍的机会。然而,这些可以通过主动监测、早期诊断和身体活动来预防。代谢综合征是一组会增加患 CAD、糖尿病、高血压和其他严重健康问题风险的疾病。 2 型糖尿病已经是一个主要的公共卫生问题,并且在与肥胖相关的儿童和年轻人中发病率越来越高。根据世界卫生组织(WHO)的数据,2019年糖尿病是导致150万人死亡的直接原因,而所有糖尿病死亡人数的48%发生在70岁之前。另有46万人因肾病死亡是由糖尿病引起的。血糖升高导致约 20% 的心血管死亡。
高血压是全世界心血管疾病和过早死亡的主要原因。根据对人口中高血压患病率、检测、治疗和控制趋势的首次全面全球分析,过去 30 年中,30-79 岁成年人患有高血压的人数从 6.5 亿增加到 12.8 亿。伦敦帝国理工学院和世界卫生组织。
欧洲内皮功能障碍市场细分为英国、德国、意大利、法国、西班牙和欧洲其他国家。心血管疾病患病率的上升、人口老龄化的增加以及研发活动的增加是促进该地区市场增长的关键因素。此外,产品发布和政府投资将促进预测期内的市场增长。
欧洲内皮功能障碍市场按原因、测试类型、最终用户和国家/地区进行细分。
基于因此,欧洲内皮功能障碍市场分为高血压、高胆固醇血症、肥胖、糖尿病、白塞氏病等。 2022年,高血压细分市场在欧洲内皮功能障碍市场份额最大。
根据测试类型,欧洲内皮功能障碍市场分为侵入性检测和非侵入性检测。到 2022 年,侵入性测试领域将在欧洲内皮功能障碍市场中占据更大份额。非侵入性测试领域进一步细分为血流介导扩张、外周动脉张力测定 (PAT)、静脉闭塞体积描记术、循环标记物等。
根据最终用户,欧洲内皮功能障碍市场已分为医院、诊断中心、诊所等。到 2022 年,医院细分市场在欧洲内皮功能障碍市场中占有最大份额。
根据国家/地区,欧洲内皮功能障碍市场分为英国、德国、意大利、法国、西班牙和其他地区欧洲。德国在 2022 年主导欧洲内皮功能障碍市场。
ZOLL Medical Corp、Sphingo Tec GmbH、The Polymath Co、SMART Medical Ltd、Alam Medical SaRl 和 Medizinische Messtechnik GmbH 是运营该领域的领先公司之一在该地区的内皮功能障碍市场。
Strategic insights for Europe Endothelial Dysfunction involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 611.28 Million |
Market Size by 2028 | US$ 776.37 Million |
Global CAGR (2022 - 2028) | 4.1% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 病因
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Endothelial Dysfunction refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Endothelial Dysfunction Market is valued at US$ 611.28 Million in 2022, it is projected to reach US$ 776.37 Million by 2028.
As per our report Europe Endothelial Dysfunction Market, the market size is valued at US$ 611.28 Million in 2022, projecting it to reach US$ 776.37 Million by 2028. This translates to a CAGR of approximately 4.1% during the forecast period.
The Europe Endothelial Dysfunction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Endothelial Dysfunction Market report:
The Europe Endothelial Dysfunction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Endothelial Dysfunction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Endothelial Dysfunction Market value chain can benefit from the information contained in a comprehensive market report.